SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns upcoming earnings report is the main focus, with traders looking for evidence that AI-driven memory demand and tight DRAM/HBM supply will support results and forward guidance. Optimism about the memory cycle competes with concerns that expectations are elevated, the cycle may be nearing a peak, and strong results could still be followed by a selloff.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidias record expansion of its share-repurchase authorization is the dominant catalyst, with traders viewing it as a sign of confidence and a potential source of support. Others question whether an authorization will translate into actual purchases, and debate whether the stocks limited gains and difficulty clearing resistance reflect broader market pressure or fading enthusiasm; the new AI-agent safety platform is also being discussed.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas selection for the U.S. Armys ALATTIS prototype program to develop 10 kV silicon-carbide devices and validate domestic manufacturing is the main catalyst. Traders view it as defense and technology validation with potential AI and grid applications, while others caution that it is a prototype award with undisclosed terms and no clear near-term revenue; discussion also includes speculation about a short squeeze.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiaks shares surged after Zenkuda and KSI-501 met primary endpoints in the Phase 3 DAYBREAK wet AMD trial, boosting expectations for a planned regulatory filing and potential commercialization. Traders are debating whether the clinical win justifies the sharp repricing, with concerns about competition and future financing needs alongside bullish talk of short covering.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Pharvariss positive Phase 3 results for an oral hereditary angioedema prevention drug have intensified concerns about future competition for BioCrysts Orladeyo, contributing to selling and bearish analyst commentary. Some investors argue the rival is still years from market and point to Orladeyos established patient base and BioCrysts pipeline as reasons for optimism.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

CRO is drawing attention as it rebounds toward the closely watched seven-cent level, with bullish traders looking for a breakout while skeptics point to persistent supply-dilution concerns and weak performance. Some holders also cite Crypto.coms new app and a shift toward revenue-funded staking as potential positives, though confidence remains divided.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Rising Treasury yields are the dominant concern, with traders linking higher rates to pressure on SPY and also discussing oil, Iran-related uncertainty, and AI-sector worries. The reaction is divided: bearish traders warn of further downside, while others expect a bounce, leaving the conversation focused on volatile, two-way trading.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is drawing attention after a sharp pullback, with traders citing selling pressure from newly unlocked shares and worries that AI tools could disrupt design software and weigh on SaaS stocks. The debate is split between bears expecting further downside and investors treating the selloff as a buying opportunity, pointing to Figmas AI monetization potential and a possible software-sector rebound.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

Anthropic IPO anticipation is a major focus, with traders treating VCXs private-tech holdings as a possible proxy for upcoming listings; the timing and impact of any IPO remain speculative. Debate also centers on newly tradable shares and whether VCXs market price still carries too large a premium to NAV, with bulls emphasizing IPO upside and bears warning of continued selling pressure.

Akamai Technologies, Inc. is the cybersecurity and cloud computing company that powers and protects business online. The market security solutions, superior threat intelligence, and global operations team provide defense in depth to safeguard enterprise data and applications everywhere. The firm full-stack cloud computing solutions deliver performance and affordability on the world’s most distributed platform. The global enterprises trust Akamai to provide the industry reliability, scale, and expertise they need to grow their business with confidence. The company was founded by Frank T. Leighton, Jonathan Seelig, Randall S. Kaplan, and Daniel M. Lewin on August 20, 1998 and is headquartered in Cambridge, MA.

Akamai Technologies Inc

Akamais large, multi-year Anthropic cloud-computing agreement has put the stock in focus, but shares gave back much of their initial gain. Bulls see the deal as validation of its AI infrastructure strategy and a growth opportunity, while skeptics cite upfront capital spending, delayed revenue, customer concentration and potential dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

https://www.marketbeat.com/earnings/reports/2026-8-10-nu-skin-enterprises-inc-stock/

$NUS Nu Skin Enterprises Earnings Transcript

Nu Skin Enterprises announced their Q2 2026 earnings on 8/10/2026. View NUS' earnings results, press release, and conference call transcript at MarketBeat.